Effects of (L)-cystine and (L)-theanine supplementation on the common cold: a randomized, double-blind, and placebo-controlled trial.

Shigekazu Kurihara, Takenori Hiraoka, Masahisa Akutsu, Eiji Sukegawa, Makoto Bannai, Susumu Shibahara

Journal: Journal of amino acids 2012;2010():307475

PMID: 22331996

Plain Language Summary

plain language summary logo

The common cold is one of the most frequent illnesses caused by viral infection. A recent study in mice demonstrated that the amino acids cysteine and theanine are associated with enhanced immune activity. The aim of this randomised controlled study was to investigate the effects of cysteine and theanine supplementation on the common cold in humans. A total of 176 healthy male volunteers were divided into two groups and given either supplements containing 700mg of cysteine and 280mg of theanine daily, or a placebo, for 5 weeks. During the trial, the group taking the supplement experienced significantly fewer colds than the placebo group (11.4% Vs 27.1%, p=0.011). The incidence of chills and fever was significantly lower in those taking cysteine and theanine. The average duration of the colds was approximately 10% less in the supplement group than in the placebo group, although this difference was not significant. The authors propose that cysteine and theanine increases glutathione synthesis and antibody production. The results suggest that cysteine and theanine supplementation may be useful for the prevention of the common cold.

Abstract

The common cold is one of the most frequent illnesses caused by viral infection. Recently, we have reported that oral administration of cystine and theanine (CT) to mice enhanced the humoral immune response associated with antibody production. Based on this mouse study, we investigated the effects of CT supplementation on the common cold in humans as a pilot study. A total of 176 healthy male volunteers were randomized to receive either placebo or CT (490 mg) tablets twice daily for 35 days. The incidence outcome was assessed using the definition in our laboratory based on questionnaires regarding cold symptoms. The incidence of subjects with colds during the trial was significantly lower in the CT group than in the placebo group, although the duration of the colds was not significantly different between the groups. These results suggest that CT supplementation may be useful for the prevention of the common cold.

Address: Research Institute for Health Fundamentals, Ajinomoto Co., Inc., Kanagawa 210-8681, Japan.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.